5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
NEUTRAL | NEUTRAL | NEUTRAL | SELL | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | N/A | N/A | N/A | 17.14▼ | 17.55▼ |
MA10 | N/A | N/A | N/A | 17.43▼ | 17.10▼ |
MA20 | N/A | N/A | N/A | 17.66▼ | 16.14▲ |
MA50 | N/A | N/A | N/A | 16.94▼ | 15.10▲ |
MA100 | N/A | N/A | N/A | 16.04▲ | 13.46▲ |
MA200 | N/A | N/A | N/A | 15.34▲ | 12.61▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | N/A | N/A | N/A | -0.147▼ | 0.064▲ |
RSI | N/A | N/A | N/A | 44.591▼ | 56.404▲ |
STOCH | N/A | N/A | N/A | 11.861▼ | 73.499 |
WILL %R | N/A | N/A | N/A | -100.000▼ | -37.500 |
CCI | N/A | N/A | N/A | -131.446▼ | 32.196 |
Thursday, April 18, 2024 04:34 AM
Smith+Nephew (NYSE:SNN; LSE:SN), the global medical technology company is pleased to announce exciting data for its ALLEVYN LIFE Dressing in a ...
|
Thursday, April 18, 2024 04:14 AM
Smith+Nephew (NYSE:SNN; LSE:SN), the global medical technology company is pleased to announce exciting data for its ALLEVYN LIFE Dressing in a recent study by Professor Amit Gefen and his research gro ...
|
Thursday, April 18, 2024 03:27 AM
UK pharma major GSK (LSE: GSK) has announced positive results from the pivotal EAGLE-1 Phase III trial for gepotidacin, a potential first-in-class oral antibiotic with a novel mechanism of action ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
17/04/24 | 16.90 | 16.90 | 16.90 | 16.90 | 12 |
16/04/24 | 17.50 | 17.54 | 17.50 | 17.50 | 110 |
15/04/24 | 16.90 | 16.90 | 16.90 | 16.90 | 278 |
12/04/24 | 16.94 | 16.94 | 16.90 | 16.90 | 13 |
11/04/24 | 18.10 | 18.10 | 17.52 | 17.52 | 163 |
10/04/24 | 18.10 | 18.10 | 17.52 | 17.52 | 400 |
09/04/24 | 18.10 | 18.10 | 17.7238 | 18.10 | 15,952 |
08/04/24 | 17.72 | 17.83 | 17.72 | 17.72 | 9,347 |
05/04/24 | 17.34 | 18.4256 | 17.34 | 17.93 | 2,507 |
04/04/24 | 17.34 | 17.83 | 17.34 | 17.34 | 1,487 |
|
|
||||
|
|
||||
|
|